Royalty Pharma plc number of employees

Royalty Pharma plc reported 100 employees at December 31, 2025 in its latest annual report, up 1 (1.0%) on the year before. That compares with 66 at December 31, 2021. Revenue per employee was $23.8m.

Headcount by year

Fiscal year end	Employees	Change	Revenue per employee	Source
December 31, 2025	100	+1 (1.0%)	$23.8m	10-K, filed February 11, 2026
December 31, 2024	99	+10 (11.2%)	$22.9m	10-K, filed February 12, 2025
December 31, 2023	89	+14 (18.7%)	$26.5m	10-K, filed February 15, 2024
December 31, 2022	75	+9 (13.6%)	$29.8m	10-K, filed February 15, 2023
December 31, 2021	66	—	$34.7m	10-K, filed February 15, 2022

What the annual reports say

Employees As of December 31, 2025, we had 100 employees. 2025 annual report
As of December 31, 2024, the Manager had 99 employees. 2024 annual report
As of December 31, 2023, the Manager had 89 employees. 2023 annual report
As of December 31, 2022, the Manager had 75 employees. 2022 annual report
As of December 31, 2021, the Manager had 66 employees. 2021 annual report

Headcount as the company states it in Item 1 of its annual report (some count full-time equivalents or exclude part-time and temporary staff), at the date it gives. Years where the report states no clear total are left out rather than estimated. Changes can reflect acquisitions and disposals as well as hiring and job cuts.

Compare with peers

Head to head: AMRX vs RPRX LNTH vs RPRX PAHC vs RPRX

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Royalty Pharma plc's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Royalty Pharma plc.